Trials / Unknown
UnknownNCT03460457
Tolerance and Pharmacokinetics of TQB2450
Phase I Study of Tolerance and Pharmacokinetics of TQB2450 Injection
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the pharmacokinetic characteristics of TQB2450 in the human body, recommend a reasonable regimen for subsequent research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQB2450 | Pharmacokinetics/Dynamics Study |
Timeline
- Start date
- 2018-03-15
- Primary completion
- 2019-03-15
- Completion
- 2019-03-15
- First posted
- 2018-03-09
- Last updated
- 2018-03-09
Source: ClinicalTrials.gov record NCT03460457. Inclusion in this directory is not an endorsement.